Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1957 1
1958 1
1959 1
1960 2
1968 1
1978 1
1981 1
1982 5
1983 3
1984 3
1985 2
1986 5
1987 9
1988 17
1989 6
1990 4
1991 8
1992 4
1993 1
1994 8
1995 14
1996 11
1997 13
1998 9
1999 19
2000 9
2001 15
2002 14
2003 11
2004 7
2005 21
2006 10
2007 12
2008 14
2009 11
2010 4
2011 16
2012 12
2013 20
2014 15
2015 20
2016 18
2017 16
2018 12
2019 9
2020 12
2021 7
2022 15
2023 6
2024 6
2025 13
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

444 results

Results by year

Filters applied: . Clear all
Page 1
A proteomic profile correlates with salivary gland inflammation and disease-associated antibodies in Sjögren's disease.
Björk A, Mofors J, Meneghel L, Kvarnström M, Maeland E, Richardsdotter Andersson E, Jonsson R, Omdal R, Forsblad-d'Elia H, Magnusson Bucher S, Eriksson P, Mandl T, Olsson P, Fischer M, Norheim KB, Auglænd Johnsen SJ, Hammenfors D, Skarstein K, Jonsson MV, Appel S, Kockum I, Imgenberg-Kreuz J, Nordmark G, Wahren-Herlenius M. Björk A, et al. Among authors: jonsson r. Ann Rheum Dis. 2025 Dec 11:S0003-4967(25)04545-5. doi: 10.1016/j.ard.2025.11.013. Online ahead of print. Ann Rheum Dis. 2025. PMID: 41387154 Free article.
Primary Sjögren's Disease: a review of unmet need, outcome measures, therapeutic advances and health economic impacts. Lessons from the NEw Clinical Endpoints in primary Sjögren's Syndrome: an Interventional Trial based on stratifYing patients (NECESSITY) Innovative Health Initiative (IHI).
Bowman SJ, Seror R, Porcher R, Arends S, de Wolff L, Verstappen G, Devauchelle-Pensec V, Jousse-Joulin S, Baldini C, Bombardieri M, Pontarini E, Hueber W, Marvel J, Goswami P, Cornec D, Fisher BA, Nayar S, Barone F, Ng WF, Gottenberg JE, Bootsma H, Dörner T, Pincemin M, Bouillot C, Hammitt KM, Wahren-Herlenius M, van Roon J, Nocturne G, Laigle L, Moingeon P, Christodoulou A, Sreih AG, van Maurik A, Chen WH, Wisniacki N, Piatrova A, Jonsson R, Gergely P, Mariette X. Bowman SJ, et al. Among authors: jonsson r. Ann Rheum Dis. 2025 Jul;84(7):1068-1089. doi: 10.1016/j.ard.2025.05.004. Epub 2025 Jun 17. Ann Rheum Dis. 2025. PMID: 40527714 Free article. Review.
2023 International Rome consensus for the nomenclature of Sjögren disease.
Ramos-Casals M, Baer AN, Brito-Zerón MDP, Hammitt KM, Bouillot C, Retamozo S, Mackey A, Yarowsky D, Turner B, Blanck J, Fisher BA, Akpek EK, Baldini C, Bootsma H, Bowman SJ, Dörner T, Laing L, Lieberman SM, Mariette X, Pflugfelder SC, Sankar V, Sisó-Almirall A, Tzioufas AG, Anaya JM, Armağan B, Bombardieri M, Carsons S, de Vita S, Fox RI, Gerli R, Giacomelli R, Gottenberg JE, Hernández-Molina G, Jonsson R, Kruize A, Kwok SK, Li X, McCoy SS, Ng WF, Olsson P, Rischmueller M, Saraux A, Scofield RH, Valim V, Vitali C, Vivino F, Wahren-Herlenius M, Moutsopoulos HM; International Task Force on Nomenclature of Sjögren Disease. Ramos-Casals M, et al. Among authors: jonsson r. Nat Rev Rheumatol. 2025 Jul;21(7):426-437. doi: 10.1038/s41584-025-01268-z. Epub 2025 Jun 10. Nat Rev Rheumatol. 2025. PMID: 40494962
Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland.
Wiley MM, Radziszewski M, Khatri B, Joachims ML, Tessneer KL, Stolarczyk AM, Yao S, Li J, Pritchett-Frazee C, Johnston AA, Rasmussen A, Anaya JM, Aqrawi LA, Bae SC, Baecklund E, Björk A, Brun JG, Bucher SM, Dand N, Eloranta ML, Engelke F, Forsblad-d'Elia H, Fugmann C, Glenn SB, Gong C, Gottenberg JE, Hammenfors D, Imgenberg-Kreuz J, Jensen JL, Johnsen SJA, Jonsson MV, Kelly JA, Khanam S, Kim K, Kvarnström M, Mandl T, Martín J, Morris DL, Nocturne G, Norheim KB, Olsson P, Palm Ø, Pers JO, Rhodus NL, Sjöwall C, Skarstein K, Taylor KE, Tombleson P, Thorlacius GE, Venuturupalli SR, Vital EM, Wallace DJ, Radfar L, Brennan MT, James JA, Scofield RH, Gaffney PM, Criswell LA, Jonsson R, Appel S, Eriksson P, Bowman SJ, Omdal R, Rönnblom L, Warner BM, Rischmueller M, Witte T, Farris AD, Mariette X, Shiboski CH; Sjögren’s International Collaborative Clinical Alliance (SICCA); Wahren-Herlenius M, Alarcón-Riquelme ME; PRECISESADS Clinical Consortium; Ng WF; UK Primary Sjögren’s Syndrome Registry; Sivils KL, Guthridge JM, Adrianto I, Vyse TJ, Tsao BP, Nordmark G, Lessard CJ. Wiley MM, et al. Among authors: jonsson r. Ann Rheum Dis. 2025 Sep;84(9):1512-1527. doi: 10.1016/j.ard.2025.04.023. Epub 2025 May 30. Ann Rheum Dis. 2025. PMID: 40447495 Free article.
Herpes simplex-myelitt hos immunkompetent voksen pasient.
Jonsson R, Hatfield D, Dahlen O. Jonsson R, et al. Tidsskr Nor Laegeforen. 2025 Apr 29;145(6). doi: 10.4045/tidsskr.24.0427. Print 2025 May 13. Tidsskr Nor Laegeforen. 2025. PMID: 40366040 Free article. Norwegian.
Kynurenines and neopterin are interferon-gamma-inducible biomarkers for Sjögren's disease.
Valim V, Oliveira FR, Miyamoto ST, Serrano ÉV, Balarini GM, Tanure LA, Ferreira GA, Zandonade E, Brun JG, Jonsson M, Maeland E, Ulvik A, Ueland PM, Jonsson R, Mydel PM. Valim V, et al. Among authors: jonsson r. Rheumatology (Oxford). 2025 Jul 1;64(7):4404-4413. doi: 10.1093/rheumatology/keaf158. Rheumatology (Oxford). 2025. PMID: 40279290
444 results